Anticoagulation in new-onset postoperative atrial fibrillation: An analysis from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.

Anticoagulation Arrhythmia Cardiac surgery Coronary artery bypass surgery Postoperative atrial fibrillation

Journal

Heart rhythm O2
ISSN: 2666-5018
Titre abrégé: Heart Rhythm O2
Pays: United States
ID NLM: 101768511

Informations de publication

Date de publication:
Aug 2022
Historique:
entrez: 13 9 2022
pubmed: 14 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

New-onset postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery and is associated with increased long-term stroke and mortality. Anticoagulation has been suggested as a potential therapy, but data on safety and efficacy are scant. To determine the association between anticoagulation for POAF and long-term outcomes. Adult patients with POAF after isolated coronary artery bypass surgery (CABG) were identified through the Society of Thoracic Surgeons Adult Cardiac Surgery Database and linked to the Medicare Database. Propensity-matched analyses were performed for all-cause mortality, stroke, myocardial infarction, and major bleeding for patients discharged with or without anticoagulation. Interaction between anticoagulation and CHA Of 38,936 patients, 9861 (25%) were discharged on oral anticoagulation. After propensity score matching, discharge anticoagulation was associated with increased mortality (hazard ratio [HR] 1.16, 95% confidence interval [CI] 1.06-1.26). There was no difference in ischemic stroke between groups (HR 0.97, 95% CI 0.82-1.15), but there was significantly higher bleeding (HR 1.60, 95% CI 1.38-1.85) among those discharged on anticoagulation. Myocardial infarction was lower in the first 30 days for those discharged on anticoagulation, but this effect decreased over time. The incidence of all complications was higher for patients with CHA Anticoagulation is associated with increased mortality after new-onset POAF following CABG. There was no reduction in ischemic stroke among those discharged on anticoagulation regardless of CHA

Sections du résumé

Background UNASSIGNED
New-onset postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery and is associated with increased long-term stroke and mortality. Anticoagulation has been suggested as a potential therapy, but data on safety and efficacy are scant.
Objectives UNASSIGNED
To determine the association between anticoagulation for POAF and long-term outcomes.
Methods UNASSIGNED
Adult patients with POAF after isolated coronary artery bypass surgery (CABG) were identified through the Society of Thoracic Surgeons Adult Cardiac Surgery Database and linked to the Medicare Database. Propensity-matched analyses were performed for all-cause mortality, stroke, myocardial infarction, and major bleeding for patients discharged with or without anticoagulation. Interaction between anticoagulation and CHA
Results UNASSIGNED
Of 38,936 patients, 9861 (25%) were discharged on oral anticoagulation. After propensity score matching, discharge anticoagulation was associated with increased mortality (hazard ratio [HR] 1.16, 95% confidence interval [CI] 1.06-1.26). There was no difference in ischemic stroke between groups (HR 0.97, 95% CI 0.82-1.15), but there was significantly higher bleeding (HR 1.60, 95% CI 1.38-1.85) among those discharged on anticoagulation. Myocardial infarction was lower in the first 30 days for those discharged on anticoagulation, but this effect decreased over time. The incidence of all complications was higher for patients with CHA
Conclusion UNASSIGNED
Anticoagulation is associated with increased mortality after new-onset POAF following CABG. There was no reduction in ischemic stroke among those discharged on anticoagulation regardless of CHA

Identifiants

pubmed: 36097451
doi: 10.1016/j.hroo.2022.06.003
pii: S2666-5018(22)00146-5
pmc: PMC9463707
doi:

Types de publication

Journal Article

Langues

eng

Pagination

325-332

Informations de copyright

© 2022 Heart Rhythm Society. Published by Elsevier Inc.

Références

J Atr Fibrillation. 2018 Apr 30;10(6):1660
pubmed: 29988296
Clin Cardiol. 2012;35(7):430-6
pubmed: 22278772
Pacing Clin Electrophysiol. 2020 Nov;43(11):1295-1301
pubmed: 33078862
Am Heart J. 2004 Jul;148(1):99-104
pubmed: 15215798
Am Heart J. 2005 Apr;149(4):650-6
pubmed: 15990748
Ann Thorac Surg. 2018 May;105(5):1411-1418
pubmed: 29577925
N Engl J Med. 2016 May 19;374(20):1911-21
pubmed: 27043047
Stroke. 2019 Jun;50(6):1364-1371
pubmed: 31043148
Ann Thorac Surg. 2010 Oct;90(4):1150-6; discussion 1156-7
pubmed: 20868806
Heart Rhythm. 2010 Oct;7(10):1458-63
pubmed: 20620230
N Engl J Med. 2012 Jan 12;366(2):120-9
pubmed: 22236222
J Thorac Cardiovasc Surg. 2014 Sep;148(3):e153-93
pubmed: 25129609
Eur Heart J. 2012 Jun;33(12):1500-10
pubmed: 22246443
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006186
pubmed: 17636831
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003611
pubmed: 23440790
Can J Cardiol. 2011 Jan-Feb;27(1):91-7
pubmed: 21329866
Am Heart J. 2015 Oct;170(4):659-68
pubmed: 26386789
JACC Clin Electrophysiol. 2018 Mar;4(3):386-393
pubmed: 30089566
J Thorac Cardiovasc Surg. 2008 Feb;135(2):405-11
pubmed: 18242276
Eur J Cardiothorac Surg. 2016 Nov;50(5):e1-e88
pubmed: 27663299
Thromb Res. 2015 May;135(5):841-5
pubmed: 25776468
Circulation. 2015 May 12;131(19):1648-55
pubmed: 25769640
Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):611-9
pubmed: 24963021
Circulation. 2014 Dec 2;130(23):2071-104
pubmed: 24682348
JAMA Netw Open. 2019 May 3;2(5):e194934
pubmed: 31150082
J Am Coll Cardiol. 2018 Oct 23;72(17):2027-2036
pubmed: 30336826
Ann Thorac Surg. 2020 Jun;109(6):1646-1655
pubmed: 32247780
Ann Thorac Surg. 2021 Dec;112(6):2084-2093
pubmed: 33340521
Eur J Cardiothorac Surg. 2010 Jun;37(6):1353-9
pubmed: 20138531
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
J Am Coll Cardiol. 2008 Feb 26;51(8):793-801
pubmed: 18294562
Heart Lung Circ. 2019 May;28(5):e106-e107
pubmed: 30935623
Chest. 2005 Aug;128(2 Suppl):24S-27S
pubmed: 16167661
Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):504-511
pubmed: 29161419
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):665-672
pubmed: 28369234
J Am Coll Cardiol. 2010 Mar 30;55(13):1370-6
pubmed: 20338499
Ann Thorac Surg. 2011 Sep;92(3):1144-52
pubmed: 21871327
Circ Cardiovasc Interv. 2019 May;12(5):e007451
pubmed: 31084236
Circulation. 2004 Sep 14;110(11 Suppl 1):II45-9
pubmed: 15364837
JAMA Cardiol. 2018 May 1;3(5):417-424
pubmed: 29590304

Auteurs

Fady S Riad (FS)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.

Maria Grau-Sepulveda (M)

Duke Clinical Research Institute, Durham, North Carolina.

Oliver K Jawitz (OK)

Duke Clinical Research Institute, Durham, North Carolina.

Andrew M Vekstein (AM)

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Varun Sundaram (V)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.
Department of Cardiology, The Louise Stokes VA Medical Center, Cleveland, Ohio.

Jayakumar Sahadevan (J)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.
Department of Cardiology, The Louise Stokes VA Medical Center, Cleveland, Ohio.

Robert H Habib (RH)

The Society of Thoracic Surgeons Research Center, Chicago, Illinois.

Jeffrey P Jacobs (JP)

Division of Cardiovascular Surgery, Department of Surgery, University of Florida, Gainesville, Florida.

Sean O'Brien (S)

Duke Clinical Research Institute, Durham, North Carolina.

Vinod H Thourani (VH)

Department of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, Georgia.

Sreekanth Vemulapalli (S)

Duke Clinical Research Institute, Durham, North Carolina.

Ying Xian (Y)

Duke Clinical Research Institute, Durham, North Carolina.

Albert L Waldo (AL)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.

Joseph Sabik (J)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.

Classifications MeSH